Collegium Pharmaceutical, Inc. (COLL)
24.25
+0.25
(+1.04%)
USD |
NASDAQ |
Sep 02, 10:40
Collegium Pharmaceutical Net Income (TTM) : 47.92M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.92M |
| March 31, 2026 | 74.95M |
| December 31, 2025 | 62.87M |
| September 30, 2025 | 58.44M |
| June 30, 2025 | 36.27M |
| March 31, 2025 | 43.89M |
| December 31, 2024 | 69.19M |
| September 30, 2024 | 88.59M |
| June 30, 2024 | 99.89M |
| March 31, 2024 | 93.29M |
| December 31, 2023 | 48.16M |
| September 30, 2023 | 9.016M |
| June 30, 2023 | -11.16M |
| March 31, 2023 | -29.36M |
| December 31, 2022 | -25.00M |
| September 30, 2022 | -42.84M |
| June 30, 2022 | -35.25M |
| March 31, 2022 | 42.79M |
| December 31, 2021 | 71.52M |
| September 30, 2021 | 103.51M |
| June 30, 2021 | 106.75M |
| March 31, 2021 | 41.96M |
| Date | Value |
|---|---|
| December 31, 2020 | 26.75M |
| September 30, 2020 | 17.59M |
| June 30, 2020 | 0.198M |
| March 31, 2020 | -12.57M |
| December 31, 2019 | -22.72M |
| September 30, 2019 | -11.44M |
| June 30, 2019 | -21.83M |
| March 31, 2019 | -30.18M |
| December 31, 2018 | -39.13M |
| September 30, 2018 | -65.62M |
| June 30, 2018 | -62.38M |
| March 31, 2018 | -70.44M |
| December 31, 2017 | -74.86M |
| September 30, 2017 | -85.02M |
| June 30, 2017 | -98.20M |
| March 31, 2017 | -101.60M |
| December 31, 2016 | -94.18M |
| September 30, 2016 | -76.14M |
| June 30, 2016 | -59.06M |
| March 31, 2016 | -39.21M |
| December 31, 2015 | -27.26M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Innoviva, Inc. | 357.24M |
| Zevra Therapeutics, Inc. | 56.00M |
| Supernus Pharmaceuticals, Inc. | -109.89M |
| Indivior Pharmaceuticals, Inc. | 355.00M |
| Crinetics Pharmaceuticals, Inc. | -501.61M |